Clinical Trial Update: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pembrolizumab with radiation and an immune modulatory cocktail in cervical and endometrial/uterine cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Uterine Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Cervical Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED